fashion -WSS

fashion

author：explore 2025-10-01 04:12:11 - browse：346

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Ahead of JPM, here's who's profiting most in health care

explore

WSS

3 trends to watch in health tech's hiring outlook for 2024

Reanimated hearts work just as well for transplants, study finds

Antibiotic resistance and the global rise in human conflict

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

3 medical device trends to watch in 2024

Burning questions for the 2024 JPM Healthcare Conference

focus

fashion

focus

Affirmative action in medical school literally saved lives

Feng Zhang CRISPR delivery startup lays off quarter of staff

What does generative AI mean for health care? We asked experts

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Psychedelics group wrestles with new pharma identity

Living organ donors deserve priority status for transplants

Malaria cases in Florida and Texas: Here’s what you need to know

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Medicare details structure of new drug price negotiation program

Reanimated hearts work just as well for transplants, study finds

knowledge

The biotech scorecard for Q1: 17 stock

Feng Zhang, Grail founder join forces on new gene editing startup

Biden administration plans revamp of organ transplant system

Mom launches Girl Scout troop for LGBTQ youth in Texas

GSK Flovent asthma inhalers replaced by authorized generics

Biogen nominates mother of director’s child to replace him on board

knowledge

hotspot

explore

focus